Docetaxel + Cetuximab + Concurrent Re-Irradiation (Intensity - Modulated Radiation Therapy, IMRT) for Patients With Locoregionally Recurrent Head and Neck Cancer

NCT00713219 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

14

Enrollment

OTHER

Sponsor class

Conditions

Head and Neck Cancer

Interventions

RADIATION: IMRT, cetuximab, docetaxel

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]